MYNDBLUE’s health mission is to transform the way #Depression and #PTSD are addressed through #ArtificialIntelligence, Medical grade data and Clinical Trials
We just received FDA Breakthrough Device Designation 🎉
Our continuous MDD severity monitoring system pairs wearable data with personalized AI so clinicians can track depression between visits — not just during them.
#MentalHealth#DigitalHealth
https://t.co/RCj46s51cP
We just received FDA Breakthrough Device Designation 🎉
Our continuous MDD severity monitoring system pairs wearable data with personalized AI so clinicians can track depression between visits — not just during them.
#MentalHealth#DigitalHealth
https://t.co/RCj46s51cP
Chatbots are programed to engage/not confront.
Eagerness to please makes:
Suicidal more suicidal
Psychotic more psychotic
Grandiose more grandiose
Fanatic more fanatic
Impulsive more impulsive
Violent more violent
Social isolates more isolated
Help some/Very harmful for others.
New study of antidepressant discontinuation:
https://t.co/Objz2yvrkZ
● WD symptoms: 29%
● WD symptoms predicted relapse, but length of taper did not
● Average taper: 50 days
● Limitation: observational, high drop-out rate
Here’s an SSRI WD scale:
https://t.co/vtZu3AcfPk
👉 @MyndBlueMedTech is proud to announce the publication of a groundbreaking study in Scientific Reports (Nature Portfolio): 🔗 https://t.co/2aSk6c3NgG
🔬 Post-Traumatic Stress Disorder (PTSD), a complex disorder, affects a significant portion of the military population, as well as civilians who have experienced attacks, accidents, or assaults. However, its diagnosis remains challenging due to the subjectivity of current methods.
💡 The article highlights an innovative approach, combining machine learning and the analysis of physiological markers (heart rate, skin conductance, nictation in military personnel and veterans during an immersive simulation of a combat scenario thanks to @ArmyResearchLab ). Thus, the algorithm detects the presence of PTSD or not in participants with an accuracy of 80.95%.
🎙️ For @Denis_PhD CEO of MyndBlue: ” We are convinced that these encouraging results applied in the clinic will significantly improve the management of PTSD from its first signs, thus avoiding its chronicity. Thus, we are continuing our mission which is to offer doctors objective tools for personalized clinical monitoring and to promote predictive and preventive medicine ”.
#MentalHealth #PTSD #ArtificialIntelligence #PredictiveMedicine #MachineLearning #Innovation #MyndBlue
Today, I had the privilege of engaging with passionate PhDs scientists dedicated to supporting those on the front lines. As we navigate the AI revolution, we need Visions that deliver tangible impact.
I was inspired by Dr. Michaël Krajecki groundbreaking work on the future of AI with 🇫🇷AMIAD and Dr. Paul Sparks enduring commitment to healthcare advancement at the 🇺🇸 US Army DevCom. At @MyndBlueMedTech we’re pushing the boundaries of AI applications in mental health, contributing our part to this revolution.
PTSD and mental health challenges are global🌎issues that transcend borders. It’s crucial for our democracies to work hand in hand for the future of the upcoming generations.
Best answer to why people change in #psychotherapy was given by Alexander in 1946:
"The patient has corrective emotional experiences to repair the traumatic influence of previous experiences. This may occur in the transference relationship or in the daily life of the patient.”
Laws of Unintended Consequences:
1)Anything that can possibly be misused in DSM will certainly be misused.
2)Once DSM makes a mistake it takes on a life of its own
3)Most changes do more harm than good
4)DSM mistakes are usually unpredictable/never correctable
5)First Do No Harm!
MyndBlue Announces the Publication in Scientific Reports of the Discovery of a Predictive Biosignature in Major Depressive Disorder, Derived From Physiological Measurements of Outpatients Using Machine Learning | Business Wire https://t.co/Bp5po9poQ2
We're proud to have helped secure funding from @USNavyResearch for this work. "This innovation is an important result that will help bring the patient closer to his physician, leading to a more personalized patient management," said MyndBlue founder @Denis_PhD . 2/2
Congrats to @MyndBlueMedTech on the result of a clinical study on major depressive disorder that used AI to demostrate "the existence of a predictive biosignature in the evolution of the disease."
https://t.co/MIo44vSNur 1/
About 12 million adults in the U.S. have PTSD during a given year; take a moment to learn more about the diagnosis and treatment of PTSD in our new explainer video. #MentalHealth https://t.co/QyHAEmFM5w
Very happy to see this thought provoking primer for clinicians on the brave new world of digital mental health by @TomBrunt77 published in @TheBJPsych Advances. Hopefully coming soon to your favourite podcast!https://t.co/YnnO987MgS
Yay! Independent giving misleading credence to unbalanced accounts of ECT. Would be great if they had looked at the whole evidence. https://t.co/KvIAzoVjzB
Bravo @JonathanShedler. If we already think we have treatments that work we lose incentive to keep looking for approaches that can do better. And surely we can and must do better. @PsychToday https://t.co/luSw15gcla